Bandingkan Harga & Kinerja Mayora Indah Tbk. (MYOR) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Mayora Indah Tbk. dan Organon Pharma Indonesia Tbk.: Mayora Indah Tbk. diperdagangkan di Rp1.515 (kapitalisasi pasar 34,21 T, volume 24 jam 23,47 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Mayora Indah Tbk. jauh lebih besar — sekitar 327,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MYOR | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 34,21 T | 104,4 M |
Volume | 23,47 jt | — |
Lot | 234,67 rb | — |
Perputaran | 35,38 M | — |
Harga Rata-rata | 1.507,67 | — |
Nilai Transaksi | 35,38 M | — |
Harga Ekuilibrium Indikatif | 1.515 | — |
Volume Ekuilibrium Indikatif | 3,97 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Mayora Indah Tbk.
PT Mayora Indah Tbk (the Company) was established on February 17, 1977 is well known as one of the largest domestic manufacturers and producers of processed food in Indonesia. It was listed on the Jakarta and Surabaya Stock Exchange in May 1990. PT Mayora and its subsidiaries produce variety of consumer foods such as biscuits, wafers, candies, chocolate products, cocoa and coffee products.
Selengkapnya di halaman MYOR →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
